» Articles » PMID: 25579744

Focal and Segmental Glomerulosclerosis: Does Prognosis Vary with the Variants?

Overview
Date 2015 Jan 13
PMID 25579744
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Focal and segmental glomerulosclerosis (FSGS) is a clinicopathological entity. The following five FSGS variants: Collapsing, cellular, glomerular tip, peri-hilar and not otherwise specified (NOS) are recognized, which may have prognostic value. The aim of this study was to highlight the clinical course and outcome in the different pathological variants of FSGS and to evaluate the predictive risk factors of end-stage renal disease (ESRD). It was a retrospective analysis of biopsy-proven primary FSGS patients who presented over a period of three years. The data were collected from the clinical and biopsy records of the Nephrology Unit. There were 116 patients with biopsy-proven FSGS. The frequency of occurrence of FSGS among all cases of the nephrotic syndrome seen in our unit was 35.47%. NOS was the most common pathological variant (62.2%), followed by peri-hilar (11.2%), cellular (9.4%) and glomerular tip (7.7%), and the least common variant was collapsing (4.3%). Majority of patients with collapsing, NOS and glomerular tip variants had nephrotic range proteinuria. However, the amount of proteinuria was highest in the glomerular tip and collapsing variants. A higher percentage of patients with the collapsing and cellular variants had renal failure at the time of presentation. A higher rate of tubular and interstitial changes was seen in the collapsing and cellular variants. The collapsing and cellular variants showed lower response rate and higher rates of ESRD, while the glomerular tip lesion had the highest remission rate and the lowest rate of ESRD. Poor prognostic factors for ESRD in FSGS were initial renal insufficiency, severe tubulo-interstitial change, initial nonresponsiveness to steroids and collapsing histopathological variant. Our study suggests that histopathological classification of FSGS is of paramount importance in the management and in predicting the prognosis.

Citing Articles

A Case Report on Primary Collapsing Glomerulopathy in a Filipino Post-partum Female and An Updated Review of Literature.

Valmoria K, Alonso R Acta Med Philipp. 2024; 58(2):98-106.

PMID: 38966160 PMC: 11219514. DOI: 10.47895/amp.vi0.6457.


Clinicopathological features and medium-term outcomes of histologic variants of primary focal segmental glomerulosclerosis in adults: A retrospective study.

Jafry N, Manan S, Rashid R, Mubarak M World J Nephrol. 2024; 13(1):88028.

PMID: 38596270 PMC: 11000038. DOI: 10.5527/wjn.v13.i1.88028.


A new index for the outcome of focal segmental glomerulosclerosis.

Chan L, Danyi Y, Chen C Sci Rep. 2024; 14(1):8278.

PMID: 38594302 PMC: 11004142. DOI: 10.1038/s41598-024-59007-5.


Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review.

Carvalho de Araujo E, Garcia Campos M, Sodre A, Holanda M, Hagemann R, Teixeira Junior A Vaccines (Basel). 2024; 12(1).

PMID: 38250875 PMC: 10821173. DOI: 10.3390/vaccines12010062.


A Study of Focal and Segmental Glomerulosclerosis according to the Columbia Classification and Its Correlation with the Clinical Outcome.

Nuguri S, Swain M, De Padua M, Gowrishankar S J Lab Physicians. 2023; 15(3):431-436.

PMID: 37564237 PMC: 10411223. DOI: 10.1055/s-0043-1761930.